Literature DB >> 18411559

The sensitivity of a palm-based psychomotor vigilance task to severe sleep loss.

Nicole Lamond1, Sarah M Jay, Jillian Dorrian, Sally A Ferguson, Gregory D Roach, Drew Dawson.   

Abstract

In this study, we evaluated the sensitivity of a 5-min personal digital assistant-psychomotor vigilance test (PDA-PVT) to severe sleep loss. Twenty-one participants completed a 10-min PVT-192 and a 5-min PDA-PVT at two hourly intervals during 62 h of sustained wakefulness. For both tasks, response speed and number of lapses (RTs > 500) per minute significantly increased with increasing hours of wakefulness. Overall, standardized response speed scores on the 5-min PDA-PVT closely tracked those of the PVT-192; however, the PDA-PVT was generally associated with more lapses/minute. Closer inspection of the data indicated that when the level of sleep loss and fatigue became more severe (i.e., Day 3), the 5-min PDA-PVT was not quite as sensitive as the 10-min PVT-192 when 2- to 10-sec foreperiods were used for both. It is likely, however, that the observed differences between the two devices was due to differences in task length. Thus, the findings provide further evidence of the validity of the 5-min PDA-PVT as a substitute for the 10-min PVT-192, particularly in circumstances in which a shorter test is required and/or the PVT-192 is not as practical.

Entities:  

Mesh:

Year:  2008        PMID: 18411559     DOI: 10.3758/brm.40.1.347

Source DB:  PubMed          Journal:  Behav Res Methods        ISSN: 1554-351X


  13 in total

1.  Reliability of a single objective measure in assessing sleepiness.

Authors:  Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

2.  Longer duration electroencephalogram arousals have a better relationship with impaired vigilance and health status in obstructive sleep apnoea.

Authors:  Brett Duce; Antti Kulkas; Juha Töyräs; Philip Terrill; Craig Hukins
Journal:  Sleep Breath       Date:  2020-05-30       Impact factor: 2.816

3.  Napping on the Night Shift: A Study of Sleep, Performance, and Learning in Physicians-in-Training.

Authors:  Jennifer McDonald; Darryl Potyk; David Fischer; Brett Parmenter; Teresa Lillis; Lindsey Tompkins; Angela Bowen; Devon Grant; Amanda Lamp; Gregory Belenky
Journal:  J Grad Med Educ       Date:  2013-12

4.  Measuring attention and vigilance in the laboratory vs. online: The split-half reliability of the ANTI-Vea.

Authors:  Fernando G Luna; Javier Roca; Elisa Martín-Arévalo; Juan Lupiáñez
Journal:  Behav Res Methods       Date:  2020-09-28

5.  Learning to live on a Mars day: fatigue countermeasures during the Phoenix Mars Lander mission.

Authors:  Laura K Barger; Jason P Sullivan; Andrea S Vincent; Edna R Fiedler; Laurence M McKenna; Erin E Flynn-Evans; Kirby Gilliland; Walter E Sipes; Peter H Smith; George C Brainard; Steven W Lockley
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

6.  An adaptive-duration version of the PVT accurately tracks changes in psychomotor vigilance induced by sleep restriction.

Authors:  Mathias Basner; David F Dinges
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

7.  Partial sleep deprivation reduces phase advances to light in humans.

Authors:  Helen J Burgess
Journal:  J Biol Rhythms       Date:  2010-12       Impact factor: 3.182

8.  Maximizing sensitivity of the psychomotor vigilance test (PVT) to sleep loss.

Authors:  Mathias Basner; David F Dinges
Journal:  Sleep       Date:  2011-05-01       Impact factor: 5.849

9.  Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance.

Authors:  Stephanie J Crowley; Charmane I Eastman
Journal:  Psychopharmacology (Berl)       Date:  2012-09-22       Impact factor: 4.530

10.  CPAP Adherence is Associated With Attentional Improvements in a Group of Primarily Male Patients With Moderate to Severe OSA.

Authors:  Sean Deering; Lin Liu; Tania Zamora; Joanne Hamilton; Carl Stepnowsky
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.